
Pfizer Inc. announced Thursday that it has asked the U.S. Food and Drug Administration for emergency approval for its coronavirus vaccine to be given to children between the ages of 5 and 11. “We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat,” the… read on > read on >